Sleep Disorders News

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, lorundrostat, in adults with obstructive sleep apnea and hypertension, according to a press release.

The likelihood for obstructive sleep apnea went down by 74% among adults with optimal vs. insufficient healthy lifestyle behaviors, according to results published in BMC Pulmonary Medicine.

Healio Pulmonology has compiled the top news on sleep disorders posted in 2024.

The FDA has approved Zepbound (tirzepatide), a prescription medicine for adults with moderate to severe obstructive sleep apnea and obesity, Eli Lilly and Company announced ina press release.

Patients with obstructive sleep apnea partaking in a peer-driven intervention vs. receiving usual care and educational materials had improved CPAP adherence, according to study findings.

BOSTON — Transitioning a pediatric sleep patient to adult care requires awareness from both pediatricians and adult providers on transition barriers and recommendations, according to a presentation at the CHEST Annual Meeting.

A combination of acetazolamide and eszopiclone taken for 3 days lessened obstructive sleep apnea severity in adults, according to results published in Annals of the American Thoracic Society.

BOSTON — Black and Native American adults had elevated prevalences of obstructive sleep apnea vs. non-Hispanic white adults, and Asian adults had a low prevalence, according to data presented at the CHEST Annual Meeting.

As a result of living with obstructive sleep apnea, many patients report fatigue, lost work productivity and limits on daily activities, according to survey findings provided by Apnimed.